➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Express Scripts

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

PRIMIDONE - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for primidone and what is the scope of patent protection?

Primidone is the generic ingredient in two branded drugs marketed by Nuro Pharma, Valeant, Amneal Pharm, Anda Repository, Dr Reddys Labs Ltd, Hikma Intl Pharms, Impax Labs, Lannett, Oxford Pharms, and Watson Labs, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for primidone. Fourteen suppliers are listed for this compound.

Drug Prices for PRIMIDONE

See drug prices for PRIMIDONE

Drug Sales Revenue Trends for PRIMIDONE

See drug sales revenues for PRIMIDONE

Recent Clinical Trials for PRIMIDONE

Identify potential brand extensions & 505(b)(2) entrants

Center for Medicinal Cannabis ResearchPhase 1/Phase 2
University of California, San DiegoPhase 1/Phase 2
international essential tremor foundationPhase 1/Phase 2

See all PRIMIDONE clinical trials

Pharmacology for PRIMIDONE
Medical Subject Heading (MeSH) Categories for PRIMIDONE

US Patents and Regulatory Information for PRIMIDONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Oxford Pharms PRIMIDONE primidone TABLET;ORAL 040586-002 Feb 24, 2005 AB RX No No   Start Trial   Start Trial   Start Trial
Anda Repository PRIMIDONE primidone TABLET;ORAL 040626-001 Sep 29, 2005 AB RX No No   Start Trial   Start Trial   Start Trial
Nuro Pharma MYSOLINE primidone SUSPENSION;ORAL 010401-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Dr Reddys Labs Ltd PRIMIDONE primidone TABLET;ORAL 040862-002 Oct 3, 2008 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.